Yin Wang

Dr. Yin Wang


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2022 in Biomaterials
Verified
Journal Article
Closed access
ZLZhifang Li
Zhifang Li
CWChunmei Wang
Chunmei Wang
CDChen Dai
Chen Dai
RHRuizhi Hu
Ruizhi Hu
LDLi Ding
Li Ding
Yu ChenYu Chen
Yu Chen

23 August 2021 in Frontiers in Public Health
Verified
Journal Article
Open access
DXDemeng Xia
Demeng Xia
RYRenqi Yao
Renqi Yao
SWSheng Wang
Sheng Wang
GCGaoqi Chen
Gaoqi Chen
YWYin Wang
Yin Wang
Purpose: The coronavirus disease 2019 (COVID-19) outbreak, which began in December 2019, has not been completely controlled; therefore, COVID-19 has received much attention from countries around the world. Many related clinical studies, such as clinical trials, have been published, but to the knowledge of the authors, there has been no bibliometric analysis of these publications focusing on clinical research studies on COVID-19.Methods: Global publications on COVID-19 from January 2020 to December 2020 were extracted from the Web of Science (WOS) collection database. The VOSviewer software and CiteSpace were employed to perform a bibliometric study. In addition, we obtained information on relevant clinical trials from the website http://clinicaltrials.gov.Results: China published most of the articles in this field and had the highest number of citations and H-index. The Journal of Medical Virology published most of the articles related to COVID-19. In terms of institutions, Huazhong University of Science and Technology had the most publications, and Wang, JW received the highest number of citations.Conclusion: The diagnosis, prevention, and prognosis of COVID-19 are still the focus of attention at present. The overall analysis of the disease were identified as the emerging topics from the perspectives of epidemiology and statistics. However, finding an effective treatment remains the focus of clinical trials.

1 October 2021 in Radiology
Verified
Journal Article
Closed access
KBKe Bi
Ke Bi
RZRui-Rui Zhou
Rui-Rui Zhou
YZYi Zhang
Yi Zhang
MSMeng-Jun Shen
Meng-Jun Shen
HCHong-Wei Chen
Hong-Wei Chen
YWYin Wang
Yin Wang
The arrival time difference ratio, an analysis of pulmonary artery and bronchial artery contrast-enhanced US, can provide an accurate method to distinguish benign subpleural pulmonary lesions from ... Background US has proven valuable in the diagnosis of subpleural pulmonary lesions (SPLs); however, existing US indicators have limitations. Purpose To propose and validate a revised contrast-enhan...

8 January 2020 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
CZChengcheng Zhang
Chengcheng Zhang
LXLisha Xu
Lisha Xu
GDGuoying Deng
Guoying Deng
YDYajie Ding
Yajie Ding
KBKe Bi
Ke Bi
YWYin Wang
Yin Wang

3 July 2023 in Advanced Science
Verified
Journal Article
Open access
RZRuirui Zhou
Ruirui Zhou
MCMeiqi Chang
Meiqi Chang
MSMengjun Shen
Mengjun Shen
YCYang Cong
Yang Cong
Yu ChenYu Chen
Yu Chen
YWYin Wang
Yin Wang
Recent considerable technological advances in ultrasound‐based treatment modality provides a magnificent prospect for scientific communities to conquer the related diseases, which is featured with remarkable tissue penetration, non‐invasive and non‐thermal characteristics. As one of the critical elements that influences treatment outcomes, titanium (Ti)‐based sonosensitizers with distinct physicochemical properties and exceptional sonodynamic efficiency have been applied extensively in the field of nanomedical applications. To date, a myriad of methodologies has been designed to manipulate the sonodynamic performance of titanium‐involved nanomedicine and further enhance the productivity of reactive oxygen species for disease treatments. In this comprehensive review, the sonocatalytic optimization of diversified Ti‐based nanoplatforms, including defect engineering, plasmon resonance modulation, heterojunction, modulating tumor microenvironment, as well as the development of synergistic therapeutic modalities is mainly focused. The state‐of‐the‐art Ti‐based nanoplatforms ranging from preparation process to the extensive medical applications are summarized and highlighted, with the goal of elaborating on future research prospects and providing a perspective on the bench‐to‐beside translation of these sonocatalytic optimization tactics. Furthermore, to spur further technological advancements in nanomedicine, the difficulties currently faced and the direction of sonocatalytic optimization of Ti‐based therapeutic nanomedicine are proposed and outlooked.

1 March 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
GDGuoying Deng
Guoying Deng
CDChenyun Dai
Chenyun Dai
JCJinyuan Chen
Jinyuan Chen
AJAnqi Ji
Anqi Ji
JZJingpeng Zhao
Jingpeng Zhao
QWQiugen Wang
Qiugen Wang
Background: Methylprednisolone (MPS) is an important drug used in therapy of many diseases. However, osteonecrosis of the femoral head is a serious damage in the MPS treatment. Thus, it is imperative to develop new drugs to prevent the serious side effect of MPS. Methods: The potential interferences Se@SiO2 nanocomposites may have to the therapeutic effect of methylprednisolone (MPS) were evaluated by classical therapeutic effect index of acute respiratory distress syndrome (ARDS), such as wet-to-dry weight ratio, inflammatory factors IL-1β and TNF-α. And oxidative stress species (ROS) index like superoxide dismutase (SOD) and glutathione (GSH) were tested. Then, the protection effects of Se@SiO2 have in osteonecrosis of the femoral head (ONFH) were evaluated by micro CT, histologic analysis and Western-blot analysis. Results: In the present study, we found that in the rat model of ARDS, Se@SiO2 nanocomposites induced SOD and GSH indirectly to reduce ROS damage. The wet-to-dry weight ratio of lung was significantly decreased after MPS treatment compared with the control group, whereas the Se@SiO2 did not affect the reduced wet-to-dry weight ratio of MPS. Se@SiO2 also did not impair the effect of MPS on the reduction of inflammatory factors IL-1β and TNF-α, and on the alleviation of structural destruction. Furthermore, micro CT and histologic analysis confirmed that Se@SiO2 significantly alleviate MPS-induced destruction of femoral head. Moreover, compared with MPS group, Se@SiO2 could increase collagen II and aggrecan, and reduce the IL-1β level in the cartilage of femoral head. In addition, the biosafety of Se@SiO2 in vitro and in vivo were supported by cell proliferation assay and histologic analysis of main organs from rat models. Conclusion: Se@SiO2 nanocomposites have a protective effect in MPS-induced ONFH without influence on the therapeutic activity of MPS, suggesting the potential as effective drugs to avoid ONFH in MPS therapy.